Enhancing supraspinal plasticity to improve functional recovery after SCI

  • Bethea, John R, (PI)

Project: Research project

Description

Project SummaryIt is becoming increasingly evident that plasticity within supraspinal networks, induced by therapeuticinterventions, is necessary for optimal recovery of function after spinal cord injury. We have developed a novelcombination therapy of motorized bike, 5-HT replacement therapy and treadmill training that can restoreopen-field weight-supported stepping (BBB score >9) in animals with complete spinal transection. Ourpreliminary data suggest that both supraspinal neuronal and glial plasticity modulated by therapy and thatthey influence each other. The central hypothesis of this proposal is that therapy combined withstrategies to either promote beneficial neural/glial plasticity and/or attenuate deleterious plasticity (e.g.,astrogliosis and inflammation) will enhance supraspinal remodeling and improve functional outcome. This Aimwill be addressed with two Specific Aims. Aim 1: Investigate the impact of therapy on functional recovery andsupraspinal plasticity after SCI as measured by changes in neurons and glial cells and their relationship tofunctional recovery. Aim 2: Determine if combining NCTherapy with: (A) strategies to enhance supraspinalplasticity (e.g. via brain-machine interface (BMI) training) and/or (B) inhibiting aspects of reactive gliosis (e.g.modulate TNF activity) is more effective than NCTherapy alone in improving functional recovery after SCI. Theresults of this work will aid in the development of therapies for recovery of volitional control of movement.Moreover, results could be used for translational research to develop assistive devices to maintain balance(e.g. cortical control of an exoskeleton or functional electrical stimulation). Glial plasticity is defined as achange in the number and or ?activation? of astrocytes and microglia in response to SCI or therapy after SCI.Neuronal plasticity includes changes in the organization of sensorimotor cortex and in neuronal firing patternsthat carry information about sensory and motor events. The combined Bethea and Moxon labs haveextensive experience measuring and manipulating glial and neuronal plasticity after spinal cord injury. Bycombining expertise, we can address, for the first time, how these two systems, neuronal and glial, interactto promote functional recovery. We will compare results from a series of 9 Experiments in animals with acomplete spinal transection to those with a severe spinal contusion. These Experiments will assesselectrophysiology changes (Experiments 1-4), the effect of lesioning the reorganized cortex (Experiment 5)and trace the source of this reorganization (Experiment 6). In Experiment 7, the impact of therapy ondifferences in spared fibers that cross the lesion will be measured. Finally, difference in the proteins/genes associated with neuroplasticity and inflammation in the brains of animals will be comparedbetween transected and contused animals (Experiments 8 and 9).
StatusActive
Effective start/end date6/1/165/31/21

Funding

  • National Institutes of Health: $602,139.00

Fingerprint

Neuronal Plasticity
Neuroglia
moxonidine
Therapeutics
Contusions
Spinal Cord Injuries
Brain-Computer Interfaces
Self-Help Devices
Gliosis
Translational Medical Research
Electrophysiology
Recovery of Function
Microglia
Encephalitis
Astrocytes
Electric Stimulation
Serotonin
Inflammation
Neurons
Weights and Measures